Filippo Milano, MD
Enriched profileAssociate Professor, Fred Hutch Cancer Center · Fred Hutch Cancer Center
Filippo Milano is Associate Professor, Fred Hutch Cancer Center at Fred Hutch Cancer Center. OpenAlex indexes 278 publications with 4,404 citations (h-index 34); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 23 Oct 2026
Filippo Milano, M.D., is Associate Professor, Fred Hutch Cancer Center. The public record shows 278 publications with 4,404 citations (h-index 34), centered on Hematopoietic Stem Cell Transplantation, Transplantation: Methods and Outcomes, CAR-T cell therapy research. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 7 companies, 1 NIH-funded awards (2018–2020).
- Most recent indexed publication: 2026 · Blood advances
- Top research focus: Hematopoietic Stem Cell Transplantation
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 75.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
Sponsor: Fred Hutchinson Cancer Center
- CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease
Sponsor: Fred Hutchinson Cancer Center
Industry payments
Updated 23 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gamida Cell Inc.Program year20253 payments$18,277openpaymentsdata.cms.gov ↗
- Medexus Pharma, Inc.Program year20253 payments
- Medexus Pharma, Inc.Program year20245 payments
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Osmotically acting laxatives100%Magnesium Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 23 Oct 2026
1 NIH research award on record, funded 2018–2020 per NIH RePORTER. The latest:
- CCR5 Analyses in HIV Infected Hematology Patients undergoing Umbilical Cord Blood Allogeneic Transplantation
Fred Hutchinson Cancer Center
FY2020$245,239R34HL142322 - CCR5 Analyses in HIV Infected Hematology Patients undergoing Umbilical Cord Blood Allogeneic Transplantation
Fred Hutchinson Cancer Research Center
FY2020$1R34HL142322 - CCR5 Analyses in HIV Infected Hematology Patients undergoing Umbilical Cord Blood Allogeneic Transplantation
Fred Hutchinson Cancer Research Center
FY2019$251,700R34HL142322
Congress activity
Updated 23 Oct 2026
39 congress contributions (2012–2025) across ASCO, ASH per OpenAlex. The most recent:
- Avoidance of ATG improves outcomes in double-cord blood transplantation for hematological malignancies
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- "Immunologic dream team": BiTEs periallotransplant to redirect donor lymphocytes toward GVL.
Blood advances
Case Report2026 - Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.
Journal of clinical oncology
Article2026 - Safety and Clinical Outcomes of Pooled Donor, Nonengrafting Expanded Progenitor Cells in Single-Unit Cord Blood Transplantation.
Journal of clinical oncology
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01Cord-Blood Transplantation in Patients with Minimal Residual DiseaseArticle445 citations2016
- 02
- 03
- 04
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/filippo-milano-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
astct.org/Nucleus/Article/astct-spotlight-dr-filippo-milano-md-phd
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →astct.org ↗ - Other
fredhutch.org/en/news/center-news/2025/04/filippo-milano-cord-blood-research-endowed-chair.html
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗ - Other
fredhutch.org/en/people/m/filippo-milano.html
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University La Sapienza
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - PhD
University La Sapienza
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Editorial & leadership roles
journal and society appointments- Director at Large
ASTCT (American Society for Transplantation and Cellular Therapy)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →astct.org ↗ - Member
ASTCT Board of Directors
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →astct.org ↗
Awards & honors
honors on the public record- Endowed Chair in Cord Blood Research
Fred Hutch (inaugural)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Secondary affiliations
appointments beyond the home institution- Professor
Division of Hematology and Oncology, University of Washington School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Member
Immunotherapy Integrated Research Center (IIRC), Fred Hutch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Emily White
Fred Hutch Cancer Center
Kavita Dhodapkar, MD
Fred Hutch Cancer Center
Eric Holland, MD
Fred Hutch Cancer Center
Sunil Hingorani, MD, PhD
Fred Hutch Cancer Center
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center